Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled, Double-blind, Randomized Trial to Compare the Effect of Different Doses of ALN-PCSSC Given as Single or Multiple Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C

NCT02597127 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT02597127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02597127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled, Double-blind, Randomized Trial to Compare the Effect of Different Doses of ALN-PCSSC Given as Single or Multiple Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C
Lead sponsor
The Medicines Company
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
June 7, 2017
Enrollment
501 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, diabetes, familial hypercholesterolemia